FHA
FLNA

Flagship Harbor Advisors’s Filana Therapeutics FLNA Stock Holding History

Flagship Harbor Advisors’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-620
Closed -$1.23K – 1901
2025
Q4 		$1.23K Buy
+620
New +$1.99K ﹤0.01% 1913

Other funds holding FLNA

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Flagship Harbor Advisors's FLNA Position: Q1 2026 in Review

Flagship Harbor Advisors sold out of Filana Therapeutics (FLNA) in Q1 2026, closing a stake of 620 shares — an estimated $1.23K sold.

Flagship Harbor Advisors first reported a position in FLNA in Q4 2025 and held it in 1 quarter. The position peaked at $1.23K in Q4 2025. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

  • Flagship Harbor Advisors reported no remaining Filana Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Flagship Harbor Advisors sold 620 Filana Therapeutics shares in Q1 2026, an estimated $1.23K.
  • Flagship Harbor Advisors first reported a position in Filana Therapeutics in Q4 2025 and held it in 1 quarter.
  • Flagship Harbor Advisors's Filana Therapeutics position peaked at $1.23K in Q4 2025.
  • 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on Flagship Harbor Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.